کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3375319 1219671 2009 6 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China
موضوعات مرتبط
علوم زیستی و بیوفناوری ایمنی شناسی و میکروب شناسی میکروبیولوژی و بیوتکنولوژی کاربردی
پیش نمایش صفحه اول مقاله
Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China
چکیده انگلیسی

SummaryObjectiveTo investigate the prevalence of occult hepatitis B virus (HBV) infection among hepatopathy patients and healthy people in China.MethodsThe HBV DNA in 653 sera samples collected from cryptogenic chronic liver disease patients (159), hepatitis B surface antigen (HBsAg) negative hepatocellular carcinoma (HCC) patients (135) and HBsAg-negative healthy people (359) were tested by nested PCR using specific primers of the X region of the HBV genome. We performed real-time PCR to determine the levels of serum HBV–DNA.ResultsPrevalence of occult HBV infection was 28.3% (45/159), 70.4% (95/135) and 10.6% (38/359) in cryptogenic chronic liver disease patients, HBsAg-negative HCC patients and HBsAg-negative healthy people, respectively. The prevalence of occult HBV infection in IgG anti-HBc-positive subjects was 100% (45/45), 86.7% (85/98) and 33.3% (14/42) in cryptogenic chronic liver disease patients, HBsAg-negative HCC patients and HBsAg-negative healthy people, respectively. In all cases, viral loads were low (<104 viral copies/mL).ConclusionThe prevalence of occult HBV infection was significantly high among hepatopathy patients and healthy people in China. Thus, more meticulous attention should be given to prevent HBV transmission by blood transfusion or organ transplantation in endemic areas, and further studies on clinical implication and mechanism of occult HBV infection are required.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Infection - Volume 58, Issue 5, May 2009, Pages 383–388
نویسندگان
, , , , , , , , , ,